Features | Partner Sites | Information | LinkXpress
Sign In
BioConferenceLive
JIB
GLOBETECH PUBLISHING

Customizable Plate Mover Module Automates Routine Lab Work

By BiotechDaily International staff writers
Posted on 15 Feb 2012
Image: The Orbitor RS microplate mover (Photo courtesy of Thermo Scientific).
Image: The Orbitor RS microplate mover (Photo courtesy of Thermo Scientific).
A fully customizable plate mover module extends the functionality and versatility of liquid handling systems used in biotech, drug discovery, and other life science research and production laboratories.

The Thermo Scientific (Milford, MA, USA) Orbitor BenchTrak module was made to interface with the already well-established Orbitor RS plate mover system.

The Orbitor RS is a high-speed microplate mover offering proven, reliable performance with flexible plate handling. Extensive vertical reach allows multiple stacked or high-density instruments to be loaded in a small footprint, and a bidirectional telescoping arm provides superior reach, improved user safety, and unlimited base rotations within a 360 degree workspace. The Orbitor RS is equipped with integrated storage for 72 plates, and its adaptable design expands to accommodate up to 360 plates. A collision and plate sensing mechanism automatically shuts down the system if the mover senses contact.

The new Orbitor BenchTrak significantly extends the functionality and versatility of Orbitor RS, providing a fully customizable automation solution that fits into existing laboratory space. BenchTrak comprises a range of “click-in” components, such as instrument loading platforms, mezzanines, guarding and microplate stores that can be easily incorporated to address almost any customer workflow requirement.

The Orbitor Benchtrak is operated via PC using Thermo Scientific’s Momentum Three software, which enables users to configure it for a wide variety of benchtop workflows including sample preparation, ELISA, nucleic acid and protein purification, cell or biochemical assays, qPCR and next-generation sequencing. The new Thermo Scientific LOCaMotion touch screen teaching wizard guides users through the configuration process.

The Orbitor BenchTrak is available for both new systems and field upgrades for existing Orbitor RS workstations, enabling systems to grow with the laboratory needs.

Related Links:
Thermo Scientific



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: In the liver tissue of obese animals with type II diabetes, unhealthy, fat-filled cells are prolific (small white cells, panel A). After chronic treatment through FGF1 injections, the liver cells successfully lose fat and absorb sugar from the bloodstream (small purple cells, panel B) and more closely resemble cells of normal, non-diabetic animals (Photo courtesy of the Salk Institute for Biological Studies).

Fibroblast Growth Factor 1 Treatment Restores Glucose Control in Mouse Diabetes Model

A "vaccine" based on the metabolic regulator fibroblast growth factor 1 (FGF1) removed the insulin resistance that characterizes type II diabetes and restored the body's natural ability to manage its glucose... Read more

Drug Discovery

view channel
Image: Molecular rendering of the crystal structure of parkin (Photo courtesy of Wikimedia Commons).

Cinnamon Feeding Blocks Development of Parkinson's Disease in Mouse Model

A team of neurological researchers has identified a molecular mechanism by which cinnamon acts to protect neurons from damage caused by Parkinson's disease (PD) in a mouse model of the syndrome.... Read more

Therapeutics

view channel
Image: This type of electronic pacemaker could become obsolete if induction of biological pacemaker cells by gene therapy proves successful (Photo courtesy of Wikimedia Commons).

Gene Therapy Induces Functional Pacemaker Cells in Pig Heart Failure Model

Cardiovascular disease researchers working with a porcine heart failure model have demonstrated the practicality of using gene therapy to replace implanted electronic pacemakers to regulate heartbeat.... Read more

Business

view channel

Cancer Immunotherapy Sector Predicted to Surge to USD 9 Billion Across Major Pharma Through 2022

The immunotherapy market will experience substantial growth through 2022, increasing from USD 1.1 billion in 2012 to nearly USD 9 billion in 2022 (corresponding to 23.8% annual growth) in the United Kingdom, United States, France, Germany, Italy, Spain, and Japan, according to recent market research. This notable growth... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.